RLYP - Relypsa

Relypsa, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of polymeric medicines for patients with conditions that are overlooked and undertreated and can be addressed in the gastrointestinal tract primarily in the United States. The company offers Veltassa (patiromer), a non-absorbed potassium binding polymer for the treatment of hyperkalemia. It has license agreement with Vifor Fresenius Medical Care Renal Pharma Ltd. for developing and commercializing Veltassa outside the United States and Japan. The company was founded in 2007 and is headquartered in Redwood City, California.

 

Biotechnology company Relypsa explores potential sale-sources

April 7 (Reuters) - Relypsa Inc, a U.S. maker of treatments for blood disorder hyperkalemia, is exploring a sale following a number of overtures from potential buyers, according to people familiar with the matter.

Relypsa is working with investment bank Centerview Partners Holdings LLC to review offers, the people said. The discussions are in their early stages and may not lead to a sale, the people added, asking not to be identified because the talks are private.

Interest in Relypsa has picked up in recent months after the $2.7 billion sale of ZS Pharma to AstraZeneca Plc, the people said. Relypsa and ZS Pharma are the primary competitors in a race to control the market for hyperkalemia treatment, which some estimates say could be worth more than $6 billion.

Several of the companies that unsuccessfully bid for ZS Pharma have reached out to Relypsa, the people said.

Relypsa declined to comment. Centerview did not respond to a request for comment.

 

Stock halted on news!

 

Now open again, just touched $24

 

I sat there thinking of shorting at $24, then waited to see if it would push above and maybe get a higher entry into the short... then PLOP! It hits $22.... crud.

Should not have waited.

 

Here is how the day ended, 1min chart:

 

Longs, I hope you get some rest tonight because tomorrow is not going to be pretty!

 

Sell off continues, now moving to some gap fill territory

 

Lets see here, this is already the 50% pullback, typically if the sellers are in control I would expect a bit deeper, so:

 

+16% rebound!

 

Going to be a bad open for RLYP -5%

 

This is roughly the channel Im watching

 

Back in the headlines with a +10% move, this turning out to be a pretty good trading stock if you can just grab these moves right! lol

 

More action on RLYP tomorrow it looks like.

 

Hey hey!

+17%

 

And holding the gains pretty well!